Senior Analyst, Corporate Development & Investor Relations
Beta Bionics, Inc.
Summary
This role is for someone with a finance background who enjoys operating beyond the traditional boundaries of a finance role. Beta Bionics is a fast-paced, entrepreneurial environment. The perfect candidate is the kind of person who is excited to take on whatever the business needs to win. While the role is expected to focus on Corporate Development, Investor Relations, and Clinical Trials, its scope will likely evolve over time based on the needs and priorities of the business.
Job description
The Senior Analyst will support the Corporate Development and Investor Relations functions while also contributing to Clinical Operations initiatives that intersect with strategic and financial priorities. This is a cross-functional role suited to an individual who can leverage financial, commercial, and clinical analysis to support M&A and strategic partnership initiatives, develop and communicate investor-facing narratives, and identify and execute on opportunities for business growth with a particular emphasis on clinical trials that shape the future of the company. This is a highly visible role, both internally and externally, reporting directly to the Head of Corporate Development and Investor Relations, collaborating frequently with C-level executives, and engaging with the capital markets.
Essential Duties and Responsibilities
Corporate Development
- Support evaluation of potential partnerships, licensing deals, and M&A opportunities, including market research, financial modeling, and due diligence
- Identify opportunities for corporate growth both commercially and clinically, and build business cases and valuation analyses to support strategic business initiatives
- Learn and monitor the diabetes technology and therapeutics landscape, including industry trends, competitor activity, and the M&A landscape
Investor Relations
- Support preparation of earnings materials, investor presentations and events, and quarterly reports
- Monitor sell-side analyst models, consensus estimates, and peer/competitor performance
- Participate in sell-side analyst and investor meetings and conferences (some travel required)
- Maintain investor website content, shareholder databases, and distribution lists
Clinical Strategy & Operations
- Partner with the Clinical Operations team to execute on key business growth initiatives that require early and/or late-stage clinical trials
- Support the development of key partnerships with clinical research institutions and clinical research vendors to initiate and execute clinical trials in an efficient manner
- Support financial and resource planning for clinical trial budgets
Requirements
- Bachelor's degree in Finance, Business, Life Sciences, Healthcare, or related field
- 2–4 years of experience in equity research, corporate development, M&A consulting/advisory, public equities investing, investment banking, or a related analytical role
- Strong financial modeling and valuation skills (Excel, PowerPoint)
- Excellent written and verbal communication skills; ability to translate financial, commercial, and clinical concepts into clear and concise messages
- High attention to detail and ability to absorb new information and manage multiple workstreams under deadline pressure
- Ability to work onsite at the San Diego, CA office five days per week
Benefits
- Medical, Dental & Vision
- FSA & HSA Options
- HSA Company Contribution
- 401(k) Matching
- Generous Vacation Accrual
- Paid Holidays
Company overview
Beta Bionics, Inc. is a pioneering medical technology company dedicated to revolutionizing diabetes management through innovative automated insulin delivery systems. Founded with a mission to improve the lives of people with diabetes, the company has developed the iLet Bionic Pancreas, an advanced closed-loop system that represents a significant leap forward in diabetes care technology. The iLet system utilizes sophisticated algorithms to automatically regulate insulin delivery based on continuous glucose monitoring data, reducing the burden of constant decision-making for patients. Beta Bionics focuses on creating user-friendly, adaptive systems that can accommodate individual variations in insulin needs and lifestyle factors. The company's technology aims to provide more stable glucose control while minimizing hypoglycemia risk, addressing critical challenges in diabetes management. With a strong emphasis on clinical validation and regulatory compliance, Beta Bionics has conducted extensive clinical trials to demonstrate the safety and efficacy of its systems. The company operates at the intersection of medical device engineering, software development, and clinical research, collaborating with healthcare professionals and diabetes specialists to ensure their solutions meet real-world patient needs. Beta Bionics represents a transformative approach to diabetes care, leveraging advanced technology to create more autonomous and effective treatment options for individuals living with this chronic condition.